-
Beyond the Algorithm: What HLTH 2025 Showed Us About the Future of Human-Centered Innovation
The pulse of HLTH 2025 At this year’s HLTH USA conference in Las Vegas, the conversation was louder—and more human—than ever. Thousands of leaders from pharma, biotech, technology, and care…
-
Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion
Comprehensive clinical operations navigation system aligns sponsors, CROs, investigators, sites and patients to improve trial planning, performance and outcomes Implementation with a top 15 global pharmaceutical company demonstratedmeasurable and significant…
-
Reverba Unveils Updated Brand Identity as Reverba Global™, Reflecting the Company’s Expansion and Global Capabilities as a Leader in Healthcare Engagement
Seattle, WA – April 07, 2025 – Reverba, a leader in healthcare engagement, today announced its rebranding as Reverba Global in response to accelerated company growth and international scope. At…
-
Change ROI to IOR: Measuring the Impact of Relationships with Patients
As we work to help biopharmaceutical and healthcare companies integrate the voice of the patient and transform their organizations by embracing patient engagement, we often hear a familiar question: “What…
-
Reverba selected as a Gold Winner in the 2024 TITAN Business Awards.
The TITAN Business Awards recognize the achievements, leadership and innovation of organizations worldwide that are driving industries forward. Seattle, WA – November 15, 2024 – Reverba, a global health engagement…
-
Listen to our CEO on: Patient Engagement Throughout the Product Lifecycle
Key considerations for effective patient engagement throughout the product lifecycle and clinical trials, and how to leverage this engagement as the industry moves forward Watch this thought-provoking video discussion as…
-
Cheryl Lubbert named in 30 Most Inspiring Leaders to Watch 2024 by The Silicon Review
An innovator ensuring patient voices are heard, driving meaningful innovations in biotech and healthcare through engagement and data. By The Silicon Review Reverba, Co-Founded by Cheryl Lubbert, is a pioneering…
-
Reverba Announces Appointment of Scott Wolf as Chief Growth Officer
Experienced expert in scaling business and growing revenue will expand Reverba’s global market reach. Seattle, WA – Reverba, a global health engagement company specializing in innovative and compliant patient engagement…
-
Reverba named top 10 Patient Engagement Solution Provider of 2024
Setting the Trend with Innovative Patient Engagement Strategies By: Cheryl Lubbert, CEO, published in Medhealth Review In the healthcare landscape, patient engagement has become a critical foundational element for achieving…
-
Building Connections for Clinical Trials: How Patients Can Improve Trial Enrollment & Engagement – Part 3
Part 3 of 3: Engaging patients before, during and after the clinical process This blog is part 3 of a series on the impact and benefits of patient involvement with…
-
Building Connections for Clinical Trials: How Patients Can Improve Trial Enrollment & Engagement – Part 2
By: Clinical Partnerships Team Part 2 of 3: How patients can improve clinical trial design This blog is part 2 of a series on the impact and benefits of patient…
-
Building Connections for Clinical Trials: How Patients Can Improve Trial Enrollment & Engagement – Part 1
By: Clinical Partnerships Team Once a promising new drug candidate reaches the clinic, many R&D challenges have already been overcome. But the goal of the clinical trial process to produce…
